{"entity":{"type":"insider","cik":"0001921163","url":"/insider/0001921163","json_url":"/insider/0001921163.json","name":"Ali Asif","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":10,"first":"2024-03-01","last":"2026-04-21","span_basis":"filed_date"},"name_variants":[{"name":"Ali Asif","source":"filing","n_filings":10,"first_seen":"2024-03-01","last_seen":"2026-04-21"}],"transactions":[{"id":6071248,"accession":"0001104659-26-046110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-046110","line_url":"/filing/0001104659-26-046110#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":105.47,"price_display":"105.47","price_state":"stated","total_value":184572.5,"total_display":"184,572.50","total_whole":"184,573","shares_owned_after":59003.0,"shares_owned_after_display":"59,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-20","filed_date":"2026-04-21","scope":"insider"},{"id":6168881,"accession":"0001104659-26-036317","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-036317","line_url":"/filing/0001104659-26-036317#line-3","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24765.0,"shares_display":"24,765","price_per_share":104.24,"price_display":"104.24","price_state":"stated","total_value":2581503.6,"total_display":"2,581,503.60","total_whole":"2,581,504","shares_owned_after":60753.0,"shares_owned_after_display":"60,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-27","scope":"insider"},{"id":5744040,"accession":"0001104659-26-007128","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-007128","line_url":"/filing/0001104659-26-007128","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46203.0,"shares_display":"46,203","price_per_share":83.1339397874597,"price_display":"83.13","price_state":"stated","total_value":3841037.42,"total_display":"3,841,037.42","total_whole":"3,841,037","shares_owned_after":78523.0,"shares_owned_after_display":"78,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-27","filed_date":"2026-01-27","scope":"insider","n_lines":2},{"id":6031556,"accession":"0001104659-26-005440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-005440","line_url":"/filing/0001104659-26-005440#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8588.0,"shares_display":"8,588","price_per_share":82.48,"price_display":"82.48","price_state":"stated","total_value":708338.24,"total_display":"708,338.24","total_whole":"708,338","shares_owned_after":78077.0,"shares_owned_after_display":"78,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":4592603,"accession":"0001104659-25-038036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-038036","line_url":"/filing/0001104659-25-038036#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1756.0,"shares_display":"1,756","price_per_share":46.0,"price_display":"46.00","price_state":"stated","total_value":80776.0,"total_display":"80,776.00","total_whole":"80,776","shares_owned_after":61065.0,"shares_owned_after_display":"61,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-22","filed_date":"2025-04-23","scope":"insider"},{"id":5043248,"accession":"0001104659-25-024062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-024062","line_url":"/filing/0001104659-25-024062#line-3","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24903.0,"shares_display":"24,903","price_per_share":58.73,"price_display":"58.73","price_state":"stated","total_value":1462553.19,"total_display":"1,462,553.19","total_whole":"1,462,553","shares_owned_after":62821.0,"shares_owned_after_display":"62,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":5042936,"accession":"0001104659-25-004569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-004569","line_url":"/filing/0001104659-25-004569#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2601.0,"shares_display":"2,601","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":62821.0,"shares_owned_after_display":"62,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":5042933,"accession":"0001104659-25-004569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-004569","line_url":"/filing/0001104659-25-004569#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1317.0,"shares_display":"1,317","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":65422.0,"shares_owned_after_display":"65,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":2875842,"accession":"0001104659-24-099838","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-099838","line_url":"/filing/0001104659-24-099838","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14203.0,"shares_display":"14,203","price_per_share":44.48861296909104,"price_display":"44.49","price_state":"stated","total_value":631871.77,"total_display":"631,871.77","total_whole":"631,872","shares_owned_after":34960.0,"shares_owned_after_display":"34,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-13","scope":"insider","n_lines":2},{"id":2284397,"accession":"0001104659-24-049567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-049567","line_url":"/filing/0001104659-24-049567#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1234.0,"shares_display":"1,234","price_per_share":25.11,"price_display":"25.11","price_state":"stated","total_value":30985.74,"total_display":"30,985.74","total_whole":"30,986","shares_owned_after":37163.0,"shares_owned_after_display":"37,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-18","filed_date":"2024-04-19","scope":"insider"},{"id":2555373,"accession":"0001104659-24-030156","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-030156","line_url":"/filing/0001104659-24-030156","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14248.0,"shares_display":"14,248","price_per_share":32.237355418304325,"price_display":"32.24","price_state":"stated","total_value":459317.84,"total_display":"459,317.84","total_whole":"459,318","shares_owned_after":40645.0,"shares_owned_after_display":"40,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-01","scope":"insider","n_lines":2},{"id":2555358,"accession":"0001104659-24-030156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-030156","line_url":"/filing/0001104659-24-030156","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001921163","owner_name":"Ali Asif","owner_display_name":"Ali Asif","owner_url":"/insider/0001921163","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9939.0,"shares_display":"9,939","price_per_share":30.691971023241774,"price_display":"30.69","price_state":"stated","total_value":305047.5,"total_display":"305,047.50","total_whole":"305,048","shares_owned_after":42734.0,"shares_owned_after_display":"42,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-01","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Officer (Chief Financial Officer)","n_filings":10,"first_seen":"2024-03-01","last_seen":"2026-04-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001921163","retrieved_at":"2026-08-23T19:17:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}